Pass H - Search Results

1

ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.

Mitsudomi T, Steinberg SM, Oie HK, Mulshine JL, Phelps R, Viallet J, Pass H, Minna JD, Gazdar AF. Mitsudomi T, et al. Among authors: pass h. Cancer Res. 1991 Sep 15;51(18):4999-5002. Cancer Res. 1991. PMID: 1654209

2

Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance.

Mulshine JL, Johnson BE, Gazdar AF, Shaw GL, Kramer BS, Mitsudomi T, Minna JD, Pass H, Phelps R, Ghosh B, et al. Mulshine JL, et al. Among authors: pass h. Lung Cancer. 1994 Mar;10 Suppl 1:S73-81. doi: 10.1016/0169-5002(94)91669-1. Lung Cancer. 1994. PMID: 8087530 Review.

3

Expression of c-myc in progenitor cells of the bronchopulmonary epithelium and in a large number of non-small cell lung cancers.

Broers JL, Viallet J, Jensen SM, Pass H, Travis WD, Minna JD, Linnoila RI. Broers JL, et al. Among authors: pass h. Am J Respir Cell Mol Biol. 1993 Jul;9(1):33-43. doi: 10.1165/ajrcmb/9.1.33. Am J Respir Cell Mol Biol. 1993. PMID: 8393325

4

Expression of surfactant associated protein-A and Clara cell 10 kilodalton mRNA in neoplastic and non-neoplastic human lung tissue as detected by in situ hybridization.

Broers JL, Jensen SM, Travis WD, Pass H, Whitsett JA, Singh G, Katyal SL, Gazdar AF, Minna JD, Linnoila RI. Broers JL, et al. Among authors: pass h. Lab Invest. 1992 Mar;66(3):337-46. Lab Invest. 1992. PMID: 1311398

5

p53: a frequent target for genetic abnormalities in lung cancer.

Takahashi T, Nau MM, Chiba I, Birrer MJ, Rosenberg RK, Vinocour M, Levitt M, Pass H, Gazdar AF, Minna JD. Takahashi T, et al. Among authors: pass h. Science. 1989 Oct 27;246(4929):491-4. doi: 10.1126/science.2554494. Science. 1989. PMID: 2554494

6

Clara cell 10 kDa protein mRNA in normal and atypical regions of human respiratory epithelium.

Jensen SM, Jones JE, Pass H, Steinberg SM, Linnoila RI. Jensen SM, et al. Among authors: pass h. Int J Cancer. 1994 Sep 1;58(5):629-37. doi: 10.1002/ijc.2910580503. Int J Cancer. 1994. PMID: 7521325

7

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.

Johnson BE, Bridges JD, Sobczeck M, Gray J, Linnoila RI, Gazdar AF, Hankins L, Steinberg SM, Edison M, Frame JN, Pass H, Nesbitt J, Holden D, Mulshine JL, Glatstein E, Ihde DC. Johnson BE, et al. Among authors: pass h. J Clin Oncol. 1996 Mar;14(3):806-13. doi: 10.1200/JCO.1996.14.3.806. J Clin Oncol. 1996. PMID: 8622028 Clinical Trial.

8

A phase II trial investigating primary immunochemotherapy for malignant pleural mesothelioma and the feasibility of adjuvant immunochemotherapy after maximal cytoreduction.

Pass HW, Temeck BK, Kranda K, Steinberg SM, Pass HI. Pass HW, et al. Among authors: pass hi. Ann Surg Oncol. 1995 May;2(3):214-20. doi: 10.1007/BF02307026. Ann Surg Oncol. 1995. PMID: 7641017 Clinical Trial.

9

Pulmonary nodules resembling bronchioloalveolar carcinoma in adolescent cancer patients.

Travis WD, Linnoila RI, Horowitz M, Becker RL Jr, Pass H, Ozols R, Gazdar A. Travis WD, et al. Among authors: pass h. Mod Pathol. 1988 Sep;1(5):372-7. Mod Pathol. 1988. PMID: 2853363 Review.

10

Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations.

Shivapurkar N, Wiethege T, Wistuba II, Salomon E, Milchgrub S, Muller KM, Churg A, Pass H, Gazdar AF. Shivapurkar N, et al. Among authors: pass h. J Cell Biochem. 1999 Dec;76(2):181-8. doi: 10.1002/(sici)1097-4644(20000201)76:2<181::aid-jcb2>3.3.co;2-0. J Cell Biochem. 1999. PMID: 10618635

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

750 results

Search Page